Posted by Michael Wonder on 27 Jul 2016
TGA approves Targin (oxycodone hydrochloride with naloxone hydrochloride trihydrate) for new indication
27 July 2016 - The TGA has approved Mundipharma's Targin (oxycodone hydrochloride and naloxone hydrochloride trihydrate).
The TGA approved Targin on 20 July 2016 for second-line symptomatic treatment of patients with severe to very severe idiopathic restless legs syndrome after failure of dopaminergic therapy.
